pazopanib_hydrochloride  - Drug Details
📊 Estimates pazopanib_hydrochloride  Dialyzability By Different_Modalities

pazopanib_hydrochloride 

Complete Drug Information

Drug Name
pazopanib_hydrochloride 
Trade Names
Votrient
Pregnancy Category
AU: D
Bioavailability
21% (14–39%)
Routes of Administration
Oral
Protein Binding
>99.5%%
Metabolism
Liver: CYP3A4 (major), 1A2 and 2C8 (minor)
Elimination
30.9±4 hours
Excretion
Faeces (primary), urine (<4%)
Formula
C21H23N7O2S
Molar Mass
437.52
Volume of Distribution
C21H23N7O2S

🤰 Pregnancy Category Information

Category: AU: D

Drugs which have caused, are suspected to have caused, or may be expected to cause an increased incidence of human fetal malformations or irreversible damage. These drugs may also have adverse pharmacological effects.